Allergy & Immunology
Dynavax reports interim Tolamba ragweed allergy results from DARTT trial
Published in Oncology Business Week, February 11th, 2007
In all three arms of the study, including the placebo arm, minimal change from baseline was observed in the main efficacy measure of the study, the total nasal symptom score (TNSS). The company indicated that in the placebo and treated groups, the change from baseline TNSS was very low; not clinically significant; and substantially lower than what has been...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Oncology Business Week
More Articles from Oncology Business Week
- Acute Myeloid Leukemia
Xanthus receives orphan drug designation of Xanafide for treating acute myeloid leukemia - Angiogenesis
Recent findings from Bayer Healthcare, Department of Cancer Biology highlight research in angiogenesis - Bladder Cancer Therapy
Research on bladder cancer therapy detailed by scientists at Memorial Sloan Kettering Cancer Center - Breast Cancer
National networks create online report to educate breast cancer patients on HER2 testing - Breast Cancer Immunology
Research from Introgen Therapeutics, Inc. in the area of breast cancer immunology published - Business & Finance
Celgene Corporation reviews 2006 achievements and announces 2007 financial outlook - More from this issue of Oncology Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
